Anti-inflammatory therapies for CVD risk prevention
Ulrich Laufs, MD, PhD
Anti-inflammatory effects of GLP-1RA in T2D
Rein Oostveen, MD
The role of inflammation in atherosclerosis
Peter Libby, MD
Jeanine Roeters van Lennep, MD, PhD
Pierre Sabouret, MD, PhD
Loading...
We’re glad to see you’re enjoying PACE-CME… but how about a more personalized experience?
Press cancel to remain on PACE-CME. Press the link below or the continue button to keep going.